AFP and hepatocellular carcinoma: The current European Association for the Study of the Liver (EASL) suggests using abdominal ultrasound (US), while the American Association of the Study of Liver Disease (AASLD) recommends US with or without alpha-fetoprotein (AFP) as a surveillance modality for HCC at six-month intervals [4,6].